Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease
Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare ketorolac, a potent, non-steroidal anti-inflammatory
drug (NSAID), with ibuprofen, a commonly used NSAID, for the treatment of the painful crisis
of sickle cell disease (SCD).
Phase:
Phase 4
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati University of Texas Southwestern Medical Center
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) University of Texas Southwestern Medical Center